Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer
Archiv der Pharmazie · 2025-05 · 358 (5)
DOI: 10.1002/ardp.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 22.05.2025. Verfasst von Mine Ensoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Institute, Ankara University, Keçiören, Ankara, Türkiye. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Ankara University., Ankara Universitesi.
Abstract (Originalsprache)
Evernic acid (EA) has emerged as a potential therapeutic agent with its low toxicity and anticancer properties. In this study, the anticancer effect of EA on ovarian cancer cell lines and normal ovarian surface epithelial cells (OSE) was evaluated. The antiproliferative effect of EA was evaluated by xCELLigence Real‐Time Cell analysis, colony formation assay, and acridine orange and DAPI staining methods. Genotoxicity analysis was performed by comet assay. The effect of EA on cell migration was analyzed by wound healing assay. The potential of EA to induce apoptosis was also determined by evaluating the changes in gene and protein expression levels by qRT‐PCR and Western blot analysis, respectively. EA was found to be a promising potential therapeutic agent for ovarian cancer without showing significant cytotoxic effect on normal cells. Furthermore, EA decreased the ability of ovarian cancer cells for migration, increased the rate of apoptosis by inhibiting BIRC5 and activating CASP3, triggered cell cycle arrest in the G2/M phase, and caused a decrease in mitochondrial membrane potential and genotoxic effects. The results have shown that EA could be an effective candidate molecule for ovarian cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Institute, Ankara University, Keçiören, Ankara, Türkiye.
ORCID-Profile: Demet Cansaran-Duman
Förderung
- This study was funded by the Ankara University.
- Ankara Universitesi
Zitieren
APA
Ensoy, M., Parıltı, D. N., Alkan, A. H., İlhan, K. N. K., Mutlu, P., Dedeoğlu, B. G., & Cansaran-Duman, D. (2025). Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer. Archiv der Pharmazie, 358(5). https://doi.org/10.1002/ardp.70015
Vancouver
Ensoy M, Parıltı DN, Alkan AH, İlhan KNK, Mutlu P, Dedeoğlu BG, et al. Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer. Archiv der Pharmazie. 2025;358(5). doi:10.1002/ardp.70015
BibTeX
@article{Ensoy2025,
author = {Ensoy, Mine and Parıltı, Damla Nur and Alkan, Ayşe Hale and İlhan, Kübra Nur Kaplan and Mutlu, Pelin and Dedeoğlu, Bala Gür and Cansaran-Duman, Demet},
title = {Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {5},
doi = {10.1002/ardp.70015}
}
EUVIMED